Summary
Verge Genomics Inc
Founded in 1996
Description
Founded by scientists from the worlds leading neurogenomics labs at UCLA, Verge focuses on accelerating drug development for neurodegenerative diseases, such as Alzheimers Disease, Amyotrophic Lateral Sclerosis (ALS), and Parkinsons Disease, utilizing its proven network algorithms.
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Verge Genomics Inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Verge Genomics Inc has a very small market share in their industry
- Variance of revenue growth is more than the industry average
Annual Revenue
Verge Genomics Inc's annual revenue
$6763000
Based on Kona Equity data
-
Revenue per employee
$211343
-
Variance of revenue growth
0.27
-
Annual revenue growth since founding
$651142
-
Revenue growth rate from first known quarter to current
75.3%
Employee Count
32 employees
-
Employee growth rate from first known quarter to current
76.9%
Executives
G Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.48 M
-
Page views per visitor
2.0
-
Daily time
2:17
-
Bounce Rate
70.0 %
Location
Unlock unlimited leads
Similar Companies
Orphazyme
orphazyme.com- Founded in 2009
- Location: Copenhagen', None
- Annual Revenue: $5.1M
- Employees: 62
- Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients wit...
Centrose LLC
centrosepharma.com- Founded in 2007
- Location: Middleton, WI
- Annual Revenue: $5.6M
- Employees: 22
- Centrose is a drug discovery company, committed to bringing the most-advanced precision therapies to patients afflicted by advanced forms of cancer and other difficult to treat diseases.
Sound Pharmaceuticals Inc
soundpharma.com- Founded in 2001
- Location: Seattle, WA
- Annual Revenue: $3.5M
- Employees: 12
- Based in Seattle, Sound Pharmaceuticals, Inc. (SPI) develops therapeutics that prevent and treat various forms of hearing loss.
ConjuChem Inc.
conjuchem.com- Founded in 1997
- Location: Los Angeles, CA
- Annual Revenue: $5.1M
- Employees: 24
- Next Generation Medicines from Therapeutic Peptides | ConjuChem LLC ConjuChem creates novel, next generation medicines using unique, long acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity ...
Retrotope Inc
retrotope.com- Founded in 2006
- Location: Los Altos, CA
- Annual Revenue: $7.4M
- Employees: 20
- Retrotope, Inc. is a drug development company advancing the idea that polyunsaturated fatty acids drugs fortified with heavy isotopes protect living cells by making bonds within the delicate molecules inside and around cells harder to break.
Second Genome Inc
secondgenome.com- Founded in 1983
- Location: South San Francisco, CA
- Annual Revenue: $9.3M
- Employees: 30
- Second Genome is a biotechnology company pioneering the field of microbiome research to develop improved ways for treating chronic disease and illness. Second Genome is discovering and developing transformational precision therapies. Second Genome offe...
Key Information
- Name: Verge Genomics Inc
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 5419; 5417
See similar companies
-
By City San Francisco Small Biotechnology Company in San Francisco Mid-size Biotechnology Company in San Francisco Biotechnology in San Francisco Small Biotechnology in San Francisco Mid-size Biotechnology in San Francisco
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 5 Founded in 1996 SIC: 80 SIC: 283 NAICS: 5419 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Verge Genomics Inc's headquarters are located at 42A Dore St. San Francisco, CA 94103.
Verge Genomics Inc's official website is vergegenomics.com
Verge Genomics Inc's annual revenue is $6.8 M.
Verge Genomics Inc's SIC: 80; 283
Verge Genomics Inc's NAICS: 5419; 5417.
Verge Genomics Inc has 32 employees
Verge Genomics Inc is in the industry of Biotechnology.
